Compare BITF & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BITF | ANIP |
|---|---|---|
| Founded | 2017 | 2001 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | N/A | N/A |
| Metric | BITF | ANIP |
|---|---|---|
| Price | $2.88 | $77.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $3.67 | ★ $105.83 |
| AVG Volume (30 Days) | ★ 39.0M | 414.8K |
| Earning Date | 11-13-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.67 |
| Revenue | $276,409,000.00 | ★ $826,880,000.00 |
| Revenue This Year | $47.67 | $44.06 |
| Revenue Next Year | $0.20 | $9.06 |
| P/E Ratio | ★ N/A | $46.97 |
| Revenue Growth | ★ 94.98 | 48.87 |
| 52 Week Low | $0.67 | $52.74 |
| 52 Week High | $6.60 | $99.50 |
| Indicator | BITF | ANIP |
|---|---|---|
| Relative Strength Index (RSI) | 53.59 | 31.39 |
| Support Level | $2.32 | $80.27 |
| Resistance Level | $2.95 | $80.29 |
| Average True Range (ATR) | 0.21 | 2.32 |
| MACD | 0.06 | -0.24 |
| Stochastic Oscillator | 90.14 | 4.53 |
Bitfarms Ltd engaged in the cryptocurrency Mining industry mainly consists of selling its computational power used for hashing calculations for cryptocurrency mining in multiple jurisdictions. Its geographic operations are currently located in Canada, the United States, Argentina. It owns and operates server farms comprised of computers designed to validate transactions on the Bitcoin Blockchain.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.